Citadel Advisors »

Cyclo Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Cyclo Therapeutics (CYTH) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Cyclo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyclo Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclo Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $86k 54k 1.59
2023-09-30 $20k 14k 1.42
2023-06-30 $27k 17k 1.59
2023-03-31 $16k 19k 0.84

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Cyclo Therapeutics

Founders Fund V Management
Vanguard Group
Founders Fund VI Management
Citadel Advisors
Wealth Enhancement Advisory Services
Princeton Global Asset Management
Wells Fargo & Company
Royal Bank of Canada
Advisor Group Holdings
New York State Common Retirement Fund
Steward Partners Investment Advisory
Jpmorgan Chase & Co
Bank of America Corporation

View all funds holding Cyclo Therapeutics